Person A/Pr Paul Timpson National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Principal investigator of Biosensor imaging in preclinical pancreatic cancer targeting: taking cancer targeting to new dimensions. (funded by National Health and Medical Research Council) Principal investigator of PARP and PI3K inhibition in pancreatic cancer: intravital insights and ‘fine-tune’ priming using AKT and single/double-strand DNA break biosensor mice. (funded by National Health and Medical Research Council) Principal investigator of Real-time optical window imaging of AKT-FRET biosensor mice to maximise PI3K/AKT drug targeting within the hypoxic microenvironment of pancreatic cancer. (funded by National Health and Medical Research Council) Principal investigator of Single-cell optical window imaging in CDK1-FRET biosensor mice to assess tissue stiffness and optimise delivery and therapeutic response to Gemcitabine/Abraxane in pancreatic cancer. (funded by National Health and Medical Research Council) Participant in Transient tissue ‘priming’ via FAK inhibition to impair pancreatic cancer progression and improve sensitivity to gemcitabine/Abraxane (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Principal investigator of Biosensor imaging in preclinical pancreatic cancer targeting: taking cancer targeting to new dimensions. (funded by National Health and Medical Research Council) Principal investigator of PARP and PI3K inhibition in pancreatic cancer: intravital insights and ‘fine-tune’ priming using AKT and single/double-strand DNA break biosensor mice. (funded by National Health and Medical Research Council) Principal investigator of Real-time optical window imaging of AKT-FRET biosensor mice to maximise PI3K/AKT drug targeting within the hypoxic microenvironment of pancreatic cancer. (funded by National Health and Medical Research Council) Principal investigator of Single-cell optical window imaging in CDK1-FRET biosensor mice to assess tissue stiffness and optimise delivery and therapeutic response to Gemcitabine/Abraxane in pancreatic cancer. (funded by National Health and Medical Research Council) Participant in Transient tissue ‘priming’ via FAK inhibition to impair pancreatic cancer progression and improve sensitivity to gemcitabine/Abraxane (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
